🇮🇱 Neuraceq in Israel

Neuraceq (FLORBETABEN) regulatory status in Israel.

Marketing authorisation

MOH

  • Marketing authorisation holder: LANTHEUS
  • Status: likely_approved

Neuraceq in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Neuroscience approved in Israel

Frequently asked questions

Is Neuraceq approved in Israel?

Yes. MOH has authorised it.

Who is the marketing authorisation holder for Neuraceq in Israel?

LANTHEUS holds the Israeli marketing authorisation.